AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇲🇼

RIVAROXABAN in Malawi

11 products registered with PMRA 0 active, 11 expired

Brand / ProductReg. No.HolderStatusExpires
XARELTO_15 15MG TABLET
TABLET
PMPB/PL116/18expired31 Mar 2025
XAFARIV_15 15MG TABLET
TABLET
PMPB/PL354/83expired31 Mar 2025
XARELTO_20 20MG TABLET
TABLET
PMPB/PL116/19expired31 Mar 2025
XARELTO_10 10MG TABLET
TABLET
PMPB/PL116/17expired31 Mar 2025
XAFARIV_2.5 2.5MG TABLET
TABLET
PMPB/PL354/84expired31 Mar 2025
XAFARIV_20 20MG TABLET
TABLET
PMPB/PL354/85expired31 Mar 2025
XAFARIV_10 10MG TABLET
TABLET
PMPB/PL354/82expired31 Mar 2025
HARTEZE 10MG TABLET
TABLET
PMPB/PL77/43expired31 Mar 2024
VAROXA_10 10MG TABLET
TABLET
PMPB/PL108/109expired31 Mar 2024
HARTEZE 15MG TABLET
TABLET
PMPB/PL77/44expired31 Mar 2024
HARTEZE 20MG TABLET
TABLET
PMPB/PL77/45expired31 Mar 2024

RIVAROXABANPMRA Registration Details

PMRA (Malawi) has 11 registered products containing RIVAROXABAN, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.

Track RIVAROXABAN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.